Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center Urges State Legislators to Regulate Opioid Prescribing and Dispensing
  • USA - English


News provided by

JoTo PR

May 23, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Bryn Wesch, CFO of Novus Medical Detox Center, comments on the need for stricter laws on prescribing opioids.
Bryn Wesch, CFO of Novus Medical Detox Center, comments on the need for stricter laws on prescribing opioids.
Youtube
Youtube

NEW PORT RICHEY, Fla. (PRWEB) May 23, 2016 -- While new U.S. opioid prescribing guidelines were recently issued to address the nation’s prescription opioid epidemic (1), physicians are not legally required to follow them. In the absence of federal regulations, many lawmakers are pursuing legislation at the state level (2, 3, 4). Novus Medical Detox Center, a leading Florida-based drug treatment facility, strongly supports new laws and regulations aimed at controlling opioid prescriptions, and believes these measures will help reduce opioid dependency, addiction and overdose deaths.

The first step in reducing opioid dependency, addiction and overdose deaths is to stop overprescribing. To that end, I believe state legislators’ efforts can have a tremendous impact.

Post this

Some states have been particularly hard hit by the current opioid epidemic and other drugs. According to the Centers for Disease Control and Prevention (CDC), 10 states have age-adjusted drug overdose death rates of 20% or higher (5). They include West Virginia (35.5%), New Mexico (27.3%), New Hampshire (26.2%), Kentucky (24.7%), Ohio (24.6%), Rhode Island (23.4%), Utah (22.4%), Pennsylvania (21.9%), Delaware (20.9%) and Oklahoma (20.3%).

Another CDC study found that many of these states also lead the nation in opioid prescriptions per capita (6). For all types of opioid pain relievers, West Virginia ranks #3, Kentucky #4 and Oklahoma #5. For long-acting opioids, Delaware ranks #2, New Hampshire #3, West Virginia #7 and Pennsylvania #9. In the case of high-dose opioids, Delaware ranks #1, West Virginia #6, New Hampshire #7 and Oklahoma #8.

“While the link between opioid prescribing practices and drug overdose deaths has not been empirically proven, the statistics appear to suggest a strong correlation,” stated Bryn Wesch, CFO of Novus Medical Detox Center. “Based on our experience in treating patients addicted to or dependent on methadone, heroin and other opioids, we’ve found that prescription painkillers often served as the gateway. That’s why we support stricter laws to regulate opioid prescribing and dispensing, and why we feel legal measures are required to overcome America’s opioid epidemic.”

Though Novus favors broad regulations at the national level, Wesch recognizes that state legislators may be able to get the job done more quickly—especially since pharmaceutical lobbyists are working to block federal initiatives. According to recent estimates, approximately 375 proposals to regulate pain clinics and/or opioid prescribing are currently circulating in state legislatures (2).

Massachusetts lawmakers recently passed a bill that would limit painkiller prescriptions to a seven-day supply, with Maine and Vermont considering similar measures (2). Delaware, which ranks in the top two for per-capita prescriptions of both long-acting and high-dose opioids, has also made news with its push for stricter regulations (3). And while Missouri remains the only state without a prescription drug monitoring program (PDMP), some state legislators have been working to change that; and several counties are pursuing PDMPs at the local level (4).

“The first step in reducing opioid dependency, addiction and overdose deaths is to stop overprescribing. To that end, I believe state legislators’ efforts can have a tremendous impact,” said Wesch. “All physicians should be legally required to follow prescribing guidelines and check their state’s PDMP before issuing prescriptions, and to refer their patients for appropriate treatment if they suspect opioid misuse or abuse.”

Novus’ medically supervised detox programs have helped many patients overcome opioid withdrawal with minimal discomfort. The Florida detox facility provides individually customized treatment plans based on proven medical protocols, including 24/7 access to withdrawal specialists and nursing care. Novus is renowned for its expertise in treating high-dose methadone cases, and is proficient in detoxing patients from other high-dose opioids just as safely, comfortably and effectively.

For more information on Novus Medical Detox Center and its prescription opioid treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center has earned The Joint Commission’s Gold Seal of Approval for Behavioral Health Care Accreditation as an inpatient medical detox facility. Licensed by the Florida Department of Children and Families, Novus provides safe, effective alcohol and drug treatment programs that are based on proven medical protocols and designed to minimize the discomfort of withdrawal. The facility is located on 3.25 acres in New Port Richey, Florida, in a tranquil, spa-like setting bordering protected conservation land. Intent on proving that detox doesn’t have to be painful or degrading, Novus set out to transform the industry by bringing humanity into medical detox with individually customized treatment programs and 24/7 access to nursing care and withdrawal specialists. Today, Novus is renowned as a champion of industry standardization and a staunch advocate of patients fighting to overcome substance use disorders. Frequently recognized for its contributions to the industry and local community, Novus has become a regular source to media publications such as The Wall Street Journal and USA Today and has ranked in the Tampa Bay Business Journal’s Fast 50, the Florida Business Journal’s Top 500 and the Inc. 5000 list of America’s fastest-growing companies. For more information on Novus’ medically supervised detox programs, visit http://novusdetox.com.

1. Centers for Disease Control and Prevention. “CDC Releases Guideline for Prescribing Opioids for Chronic Pain”; press release issued March 15, 2016. cdc.gov/media/releases/2016/p0315-prescribing-opioids-guidelines.html

2. Meier, Barry and Sabrina Tavernise. “States Move to Control How Painkillers Are Prescribed”; The New York Times; March 11, 2016. nytimes.com/2016/03/12/business/states-move-to-control-how-painkillers-are-prescribed.html

3. Rini, Jen. “State Pushes Stricter Prescribing Guidelines for Pain Pills”; The News Journal (Delaware); May 12, 2016. delawareonline.com/story/news/health/2016/05/11/state-pushes-stricter-prescribing-guidelines-pain-pills/84227258/

4. Suntrup, Jack. “Prescription Monitoring Hits Roadblock in Missouri Senate”; St. Louis Post Dispatch; May 12, 2016. stltoday.com/news/local/govt-and-politics/prescription-monitoring-hits-roadblock-in-missouri-senate/article_15c20d81-a62a-5407-93d3-6eb10d4cd2cb.html

5. Rudd, Rose A.; Noah Aleshire; et al. “Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014”; Morbidity and Mortality Weekly Report; January 1, 2016. cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm

6. Paulozzi, Leonard J.; Karin A. Mack; and Jason M. Hockenberry. “Variation Among States in Prescribing of Opioid Pain Relievers and Benzodiazepines — United States, 2012”; Morbidity and Mortality Weekly Report; July 4, 2014. cdc.gov/mmwr/preview/mmwrhtml/mm6326a2.htm

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.